Home › Funds › Casdin Capital › PLRX
Casdin Capital position in PLRX
PLIANT THERAPEUTICS INC · Health Care
Latest position (Q2 2024)1.00M sh
Reported value held$10.75M
Portfolio Weight0.82%
First reportedQ3 2022
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 750.00K | $15.67M | New |
| Q4 2022 | 1.68M | $32.38M | Add |
| Q1 2023 | 1.68M | $44.55M | Hold |
| Q2 2023 | 1.70M | $30.80M | Add |
| Q3 2023 | 1.58M | $27.35M | Reduce |
| Q4 2023 | 1.58M | $28.56M | Hold |
| Q1 2024 | 1.00M | $14.90M | Reduce |
| Q2 2024 | 1.00M | $10.75M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PLRX
- Vanguard Group 2.82M sh · $3.44M · Q4 2025
- Two Sigma Investments 2.26M sh · $2.58M · Q2 2026
- Citadel Advisors 2.14M sh · $2.44M · Q2 2026
- Renaissance Technologies 2.05M sh · $2.34M · Q2 2026
- BlackRock Inc 1.15M sh · $1.31M · Q2 2026
- Marshall Wace 835.12K sh · $952.04K · Q2 2026
- JPMorgan Chase & Co 681.65K sh · $783.89K · Q2 2026
- Geode Capital Management 578.58K sh · $659.95K · Q2 2026
- UBS Group AG 571.76K sh · $651.81K · Q2 2026
- Millennium Management 559.45K sh · $637.77K · Q2 2026
- Morgan Stanley 298.98K sh · $340.83K · Q2 2026
- Goldman Sachs Group 208.59K sh · $237.79K · Q2 2026